Summary of Study ST002856
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001788. The data can be accessed directly via it's Project DOI: 10.21228/M8KX5C This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.
| Study ID | ST002856 |
| Study Title | Validation of on-target effect of IACS-010759 in vehicle- and Enzalutamide-treated 16D cells |
| Study Summary | In this study, we sought to validate that 30nM IACS-010759, a complex I inhibitor, had an on-target effect in vehicle- and Enzalutamide-treated 16D prostate cancer cells. |
| Institute | University of California, Los Angeles |
| Laboratory | Goldstein Lab |
| Last Name | Giafaglione |
| First Name | Jenna |
| Address | 610 Charles E Young Dr S, Los Angeles, CA, 90024, USA |
| jgiafaglione@g.ucla.edu | |
| Phone | 408-728-3065 |
| Submit Date | 2023-09-11 |
| Raw Data Available | Yes |
| Raw Data File Type(s) | d |
| Analysis Type Detail | GC-MS |
| Release Date | 2023-09-13 |
| Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Treatment:
| Treatment ID: | TR002977 |
| Treatment Summary: | Vehicle- and Enzalutamide-treated 16D cells were cultured with 30nM IACS-010759 in U13C-glucose-containing media for 24 hours |
